Precision Genomics Collaboratory News

Priya Kishnani, MD, HS'91-'95, is the Chen Family Distinguished Professor of Pediatrics, chief of the Division of Medical Genetics, a professor in the Department of Molecular Genetics and Microbiology, core faculty member of the Duke Innovation and Entrepreneurship Initiatives, and member of the Duke Clinical Research Institute.

As a pediatrician, Sarah Armstrong, MD, has devoted her career to improving children’s health and well-being.

Three Duke University School of Medicine researchers were named Burroughs Wellcome Fund 2021 Investigators in the highly competitive Pathogenesis of Infectious Disease (PATH) program.

Dr. Priya Kishnani grew up in a family of physicians, including her mother, a pediatrician, in Mumbai (then Bombay), India. “My mother ran a charitable program, caring for the underserved and indigent throughout her life,” Dr. Kishnani says. “I saw firsthand what it really meant to be a physician: to give hope to your neighbors, and make an impact on the rest of their lives. From then on, I knew this was what I wanted to do.”

A new $8 million NIH grant seeks to uncover more clues into what genes increase the risk of developing schizophrenia.

Snellings, a graduate student in Doug Marchuk's lab, is co-lead author on a new publication that uses single nucleus sequencing to better understand what causes some cerebral cavernous malformations to stay small and others to grow.

Two Duke faculty members have been elected as members of the U.S. National Academy of Sciences (NAS), one of the highest honors in the profession.

The American Association for Cancer Research (AACR) has named Jen-Tsan Ashley Chi, MD, PhD, as co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence on behalf of his all-Duke research team for their paper — A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.  

Some guys have it all: the muscle, the power, the high social status, the accelerated aging.

Clinicians have historically used family health history collection as a primary method for identifying actionable disease-risk assessments. However, as large-scale genome screening programs continue to rise in popularity, the scientific community has questioned the efficacy of this traditional method, wondering at the superiority of variants identified by sequencing over family health history in identifying these risks.